Corp. (Madison, WI). BCA protein assay kits used in total cell protein assays were purchased from Pierce Biotechnology, Inc. (Rockford, IL). All other materials and solvent were used as received without any further purification unless otherwise noted.
Polymerization of 2-Vinyl-4,4-dimethylazlactone. 2-Vinyl-4,4-dimethylazlactone (VDMA) was purified by passage through inhibitor removal resin followed by passage through a plug of silica gel prior to polymerization. The initiator 2,2'-azobisisobutyronitrile (AIBN, 14.1 mg, 0.086 mmol) was weighed into a 25 mL round-bottomed flask equipped with a stir bar. Ethyl acetate (12 mL) was added and the solution was purged with N 2 for 10 minutes. VDMA (3.36 g, 24.2 mmol) was added to the flask via syringe. The N 2 purge was continued for an additional 5 minutes. The solution was stirred under N 2 at 60 °C for 24 hours. After 24 hours, the viscous reaction mixture was cooled to room temperature. Approximately 5 mL of CH 2 Cl 2 were added to the flask and the polymer was precipitated into hexanes to produce a white solid. The polymer was redissolved in CH 2 Cl 2 and precipitated twice more in hexanes to obtain a white solid in 90% yield. 1 H NMR (300 MHz, CDCl 3 , 25 °C): δ = 1.37 (br s, (-CH 3 ) 2 ), 1.62-2.1 (br m, -CH 2 CH-),
(br s, -CH 2 CH-). FT-IR (ATR, cm -1 ): 2980-2900 (C-H), 1820 (lactone C=O), 1672 (C=N).
M n = 73,873; PDI = 2.65. For experiments designed to synthesize lower molecular weight PVDMA (see text) by atom-transfer radical polymerization (ATRP): Copper(I) bromide (18.8 mg, 13.1 mmol) was added to a 10 mL round-bottomed flask equipped with a stir bar. The flask was capped with a septum and purged with N 2 for 10 mins. VDMA (3.063 g, 22 mmol) was added to the flask through a syringe. Anhydrous toluene (3 mL) and PMDETA (54.5 µL, 44.9 mg, 0.26 mmol) were added to the flask via syringe and the solution was purged with N 2 for an additional 5 mins at 50 ºC. was added to each vial. The resulting solutions were stirred at 50 °C for 24 hours. The reaction solutions were concentrated under vacuum and precipitated into an acetone/hexane solution (40 ml, 1:2 v/v). Precipitated polymer was collected by decanting the supernatant, and the polymer was precipitated twice more using the above procedure. The final products were dried under vacuum. Exhaustive functionalization of PVDMA in each case was confirmed by the absence of the carbonyl peak of the azlactone functionality of PVDMA (at 1820 cm -1 ) in each product polymer, as determined using attenuated total reflectance infrared spectroscopy. Table S1 , below. 
Gerneral Protocols for Cell Transfection Experiments and Characterization of Transgene
Expression. COS-7 cells were grown in clear or opaque 96-well culture plates (for experiments using pEGFP-N1 and pCMV-Luc, respectively) at initial seeding densities of 15,000 cells/well in 200 μL of growth medium (90% Dulbecco's modified Eagle's medium, 10% fetal bovine serum, penicillin 100 units/mL, streptomycin 100 μg/mL). After plating, all cells were incubated at 37 °C for 24 hours and transfection experiments were conducted at approximately 80% confluence.
For experiments conducted using pEGFP-N1, formulations of polyplexes (30 μL)
prepared at desired pEGFP-N1/polymer ratios (as described above, and further in the main text)
were added to cells after an initial replacement of serum-containing media (DMEM + 10% FBS)
with 200 μL of OptiMEM media. Cells were incubated for four hours, and media was aspirated from all samples and replaced with 200 μL of DMEM. Culture plates were incubated for 48 hours at 37 °C, at which point cell morphology and gene expression were visualized using phase contrast and fluorescence microscopy.
For experiments conducted using pCMV-Luc, formulations of polyplexes (30 μL) prepared at desired pCMV-Luc/polymer ratios (as described above, and further in the main text)
were added to cells after an initial replacement of serum-containing media (DMEM + 10% FBS) with 200 μL of OptiMEM media. Cells were incubated for four hours, and media was aspirated from all samples and replaced with 200 μL of DMEM. Culture plates were incubated for 48 hours at 37 °C, at which point luciferase expression and total cell protein were determined with commercially available luciferase assay kits and BCA protein assay kits, respectively, using the manufacturers' specified protocols and a PerkinElmer EnVision multilabel plate reader.
Luminescence was expressed in relative light units and was normalized to total cell protein.
For experiments conducted to evaluate the influence of polymer structure on cell viability and metabolism, formulations of polyplexes (30 μL) prepared at desired pEGFP-N1/polymer ratios (as described above) were added to cells after an initial replacement of serum-containing Relative Viability (%) Figure S1 : Characterization of the influence of polyplexes on the metabolism and viability of COS-7 cells, as determined using an MTT assay. Experiments were conducted using polyplexes formed using plasmid DNA and polymers P1-P12. Polyplexes used in each case were formed at the DNA/polymer ratios (w/w) determined to mediate the highest levels of transfection for each polymer (see text, and additional data in Supporting Information above). Experiments were performed in triplicate. Experiments performed in the absence of polymer (DNA only) and using polyplexes formed using LPEI and BPEI at DNA/polymer weight ratios of 1:2 are shown for comparison. See Materials and Methods for additional details related to the formation of polyplexes and cell culture and cytotoxicity experiments. Experiments performed with polyplexes formed using LPEI at DNA/polymer weight ratios of 1:2 are shown for comparison.
